Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer - Nicole C. Lorona; Linda S. Cook; Mei-Tzu C. Tang; Deirdre A. Hill; Charles L. Wiggins; Christopher I. Li (Cancer Causes & Control, 2021)